Early Human Cytomegalovirus Reactivation Is Associated With Lower Incidence of Relapse of Myeloproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation

Researchers studying cytomegalovirus (CMV) and myeloproliferative disorders found that a substantial reduction in relapse of myeloproliferative disorders is associated with CMV reactivation after allogeneic hematopoietic stem cell transplantation (allo-HSCT).

 Bone Marrow Transplantation

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.